Literature DB >> 2943233

Immunoregulatory treatment for minimal change nephrotic syndrome.

P F Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2943233      PMCID： PMC1777903          DOI： 10.1136/adc.61.7.718-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

1.  Inhibition of interferon or soluble immune response suppressor (SIRS) mediated suppression by levamisole.

Authors:  T M Aune; C W Pierce
Journal:  Int J Immunopharmacol       Date:  1983

2.  Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.

Authors:  P Hersey; K Ho; J Werkmeister; U Abele
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

3.  Treatment of nephrotic syndrome with levamisole.

Authors:  P Tanphaichitr; D Tanphaichitr; J Sureeratanan; S Chatasingh
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

4.  Immunoregulatory treatment for minimal change nephrotic syndrome.

Authors:  K P Mehta; U Ali; M Kutty; U Kolhatkar
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.